Target intelligence / Profile preview

NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial (NDUFS4)

Target
NDUFS4
Molecular classification
Enzyme, Accessory protein of mitochondrial respiratory chain complex I, Iron-sulfur protein
01

Overview

NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial (NDUFS4), is a nuclear-encoded accessory subunit of mitochondrial respiratory chain complex I (NADH:ubiquinone oxidoreductase). It is a peripheral membrane protein located on the matrix side of the inner mitochondrial membrane and contributes to electron transport from NADH to ubiquinone, facilitating ATP synthesis via oxidative phosphorylation. Although NDUFS4 is not directly involved in catalysis, it is essential for proper assembly and stabilization of complex I and may be regulated by phosphorylation. Mutations cause mitochondrial complex I deficiency, Leigh syndrome, and are associated with a broad spectrum of multi-organ mitochondrial diseases, especially neurological and muscular phenotypes; these disorders are often severe and clinically heterogeneous.

Other names
AQDQCI-18CI-18 kDaCI-AQDQMC1DN1Complex I-18 kDa subunitNADH-ubiquinone oxidoreductase 18 kDa subunitcomplex I 18kDa subunitCI-18 kDa subunitNADH dehydrogenase (ubiquinone) Fe-S protein 418kDa subunit (NADH-coenzyme Q reductase)mitochondrial respiratory chain complex I (18-KD subunit)
02

Mechanism of action

Direct inhibition of complex I (e.g., by rotenone, reducing electron transport and ATP production)

03

Biological functions

Electron transport (from NADH to ubiquinone) in mitochondrial respiratory chainATP production via oxidative phosphorylationRegulation/assembly/stabilization of complex I
04

Disease associations

Mitochondrial complex I deficiencyLeigh syndromeLactic acidosisNeurodegenerative diseases (including some forms of Parkinson disease)Hypertrophic cardiomyopathyLeber hereditary optic neuropathyMyopathyLiver disease
05

Safety considerations

Genetic heterogeneity (variable manifestations/difficulty in genotype–phenotype correlation)Loss-of-function mutations can cause severe multisystem mitochondrial diseases, including lethal neonatal diseaseNo established pharmacological therapies; therapeutic intervention is challenging due to essential role in mitochondrial energy production
06

Interacting drugs

Rotenone (complex I inhibitor)
07

Biomarkers

NDUFS4 mutation or deficiency (biomarker for mitochondrial complex I deficiency and Leigh syndrome)Lactate (elevated in lactic acidosis)Reduced mitochondrial complex I activityMRI/clinical markers for Leigh syndrome

Beyond the preview

Go deeper on NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial (NDUFS4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial (NDUFS4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call